Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 9 studies | 21% ± 6% | |
epithelial cell | 5 studies | 32% ± 14% | |
fibroblast | 4 studies | 19% ± 3% | |
oligodendrocyte | 4 studies | 19% ± 2% | |
plasmacytoid dendritic cell | 4 studies | 23% ± 6% | |
conventional dendritic cell | 3 studies | 22% ± 6% | |
hematopoietic precursor cell | 3 studies | 19% ± 4% | |
ciliated cell | 3 studies | 24% ± 6% | |
abnormal cell | 3 studies | 27% ± 4% | |
GABAergic neuron | 3 studies | 29% ± 5% | |
glutamatergic neuron | 3 studies | 38% ± 7% | |
dendritic cell | 3 studies | 27% ± 7% | |
basal cell | 3 studies | 24% ± 8% | |
astrocyte | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3020.82 | 1445 / 1445 | 100% | 47.12 | 183 / 183 |
ovary | 100% | 2725.45 | 180 / 180 | 100% | 77.47 | 430 / 430 |
skin | 100% | 3611.21 | 1809 / 1809 | 100% | 69.47 | 472 / 472 |
stomach | 100% | 2292.23 | 359 / 359 | 100% | 44.83 | 286 / 286 |
uterus | 100% | 3338.48 | 170 / 170 | 100% | 78.67 | 459 / 459 |
brain | 100% | 2632.61 | 2639 / 2642 | 100% | 65.90 | 705 / 705 |
liver | 100% | 1533.64 | 226 / 226 | 100% | 50.71 | 405 / 406 |
lung | 100% | 2777.30 | 578 / 578 | 100% | 61.25 | 1152 / 1155 |
thymus | 100% | 3126.75 | 653 / 653 | 100% | 52.08 | 603 / 605 |
intestine | 100% | 3108.65 | 966 / 966 | 100% | 46.56 | 525 / 527 |
prostate | 100% | 3138.92 | 245 / 245 | 100% | 54.22 | 500 / 502 |
breast | 100% | 3052.04 | 459 / 459 | 99% | 83.64 | 1112 / 1118 |
pancreas | 100% | 1382.96 | 328 / 328 | 99% | 50.53 | 177 / 178 |
bladder | 100% | 3063.67 | 21 / 21 | 99% | 62.96 | 499 / 504 |
kidney | 100% | 2455.37 | 89 / 89 | 98% | 35.50 | 885 / 901 |
adrenal gland | 100% | 2712.78 | 258 / 258 | 96% | 42.03 | 221 / 230 |
adipose | 100% | 2937.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2710.25 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 48.49 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 77.37 | 29 / 29 |
muscle | 100% | 3441.45 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3231.50 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 61.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 68.10 | 1 / 1 |
heart | 99% | 1920.00 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2680.61 | 916 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | PRCC |
Protein name | Papillary renal cell carcinoma (Translocation-associated) Proline rich mitotic checkpoint control factor Papillary renal cell carcinoma isoform 1 Papillary renal cell carcinoma isoform 2 Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein) Papillary renal cell carcinoma isoform 3 |
Synonyms | TPRC |
Description | FUNCTION: May regulate cell cycle progression through interaction with MAD2L2. . |
Accessions | A0A0S2Z456 H0Y679 Q96FT4 ENST00000526188.5 ENST00000454659.1 ENST00000271526.9 Q92733 A0A0S2Z483 H0YE12 A0A0S2Z470 |